会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • CXCR4 RECEPTOR COMPOUNDS
    • CXCR4受体化合物
    • WO2011106703A3
    • 2011-09-01
    • PCT/US2011/026322
    • 2011-02-25
    • ANCHOR THERAPEUTICS, INC.LOOBY, Richard, J.TCHERNYCHEV, Boris
    • LOOBY, Richard, J.TCHERNYCHEV, Boris
    • A61K38/16
    • The invention relates generally to compounds which are allosteric modulators {e.g., positive and negative allosteric modulators, and allosteric agonists) of the G protein coupled receptor for stromal derived factor 1 (SDF-I), also known as the CXCR4 receptor. The CXCR4 receptor compounds are derived from the intracellular loops and domains of the CXCR4 receptor. The invention also relates to the use of these CXCR4 receptor compounds and pharmaceutical compositions comprising the CXCR4 receptor compounds in the treatment of diseases and conditions associated with CXCR4 modulation such as bone marrow transplantation, chemosensitization, cancer, metastatic disease ( e.g. , cancer), auto-immune disease ( e.g ., rheumatoid arthritis), fibrosis disease ( e.g ., pulmonary), AIDS infection, cardiovascular disease, uveitis, inflammatory diseases, celiac disease HIV infection and stem cell-based regenerative medicine.
    • 本发明一般涉及用于基质衍生因子1(SDF-1)的G蛋白偶联受体的变构调节剂(例如,正向和负向变构调节剂和变构激动剂)的化合物,也是已知的 作为CXCR4受体。 CXCR4受体化合物来源于CXCR4受体的细胞内环和结构域。 本发明还涉及这些CXCR4受体化合物和包含CXCR4受体化合物的药物组合物在治疗与CXCR4调节相关的疾病和病症例如骨髓移植,化学增敏作用,癌症,转移性疾病(例如, 癌症),自身免疫疾病(例如类风湿性关节炎),纤维化疾病(例如肺癌),AIDS感染,心血管疾病,葡萄膜炎,炎症 疾病,腹腔疾病HIV感染和基于干细胞的再生医学。